Indication
Influenza Prevention
1 clinical trial
2 products
Clinical trial
A Randomized, Blind, Position-controlled Phase III Clinical Trial to Evaluate the Immunogenicity and Safety of Quadrivalent Influenza Virus Split Vaccine in 6-35 Months of AgeStatus: Completed, Estimated PCD: 2024-01-05
Product
Investigational VaccineProduct
Active compared Vaccine